However, use of these systemic and unspecific NF-κB inhibitors is associated with adverse side effects like systemic inflammation or immunodeficiency due to the pivotal role of NF-κB in both innate and adaptive immunity [109]. Here, NFKB1 is linked to Immunodeficiency.